Literature DB >> 6825218

Inhibition by carotid baroreflex of exercise-induced increases in arterial pressure.

S C Walgenbach, D E Donald.   

Abstract

Mean arterial blood pressure, heart rate, and cardiac output were measured during continuous graded exercise (5.5 km/hr; 0, 7, 14, and 21% grades) in conscious dogs, under each of the following four conditions: (1) baroreceptors intact, (2) chronic aortic arch denervation, (3) chronic aortic arch denervation and surgical preparation of the carotid sinuses for later reversible vascular isolation, and (4) chronic aortic arch denervation and carotid sinuses vascularly isolated at a fixed pressure. Arterial blood pressure increased with increasing work load to a maximum of 12 +/- 3, 18 +/- 5, and 14 +/- 5 mm Hg above control in conditions 1, 2, and 3, respectively. In condition 4, the maximum increase in pressure during graded exercise was 51 +/- 7 mm Hg above control. Upon cessation of graded exercise, the increase in arterial pressure persisted through the 5-minute recovery period. Heart rate and cardiac output increased similarly in proportion to work load under all four conditions. In contrast to dogs in condition 4, three dogs with chronic sinoaortic denervation showed no work load-related increase in arterial pressure during exercise. Thus, during exercise, the carotid baroreflex acts to balance finely the opposing effects of sympathetic vasoconstriction and metabolic vasodilation.

Entities:  

Mesh:

Year:  1983        PMID: 6825218     DOI: 10.1161/01.res.52.3.253

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  23 in total

1.  Forearm vasoconstriction during dynamic leg exercise in patients with chronic heart failure.

Authors:  J J Atherton; L G Dryburgh; H L Thomson; T D Moore; K N Wright; G W Muehle; L E Fitzpatrick; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Model simulations of cardiovascular changes at the onset of moderate exercise in humans.

Authors:  Maja Elstad; Karin Toska; Lars Walløe
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

3.  Arterial baroreflex buffering of sympathetic activation during exercise-induced elevations in arterial pressure.

Authors:  U Scherrer; S L Pryor; L A Bertocci; R G Victor
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

4.  Baroreflex failure following radiation therapy for nasopharyngeal carcinoma.

Authors:  H J Timmers; J M Karemaker; J W Lenders; W Wieling
Journal:  Clin Auton Res       Date:  1999-12       Impact factor: 4.435

Review 5.  Human investigations into the arterial and cardiopulmonary baroreflexes during exercise.

Authors:  Paul J Fadel; Peter B Raven
Journal:  Exp Physiol       Date:  2011-10-14       Impact factor: 2.969

Review 6.  Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs.

Authors:  Michael J Joyner; Darren P Casey
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

7.  Dynamic arterial baroreflex function during high intensity exercise in humans: insights into sympathetic control.

Authors:  Paul J Fadel
Journal:  J Physiol       Date:  2008-06-01       Impact factor: 5.182

8.  Forearm vascular responses during semierect dynamic leg exercise in patients following myocardial infarction.

Authors:  H Thomson; J Morris-Thurgood; J Atherton; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

9.  Altered arterial baroreflex-muscle metaboreflex interaction in heart failure.

Authors:  Jasdeep Kaur; Abhinav C Krishnan; Danielle Senador; Alberto Alvarez; Hanna W Hanna; Donal S O'Leary
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-03       Impact factor: 4.733

Review 10.  New insights into the effects of age and sex on arterial baroreflex function at rest and during dynamic exercise in humans.

Authors:  James P Fisher; Areum Kim; Doreen Hartwich; Paul J Fadel
Journal:  Auton Neurosci       Date:  2012-11-11       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.